Drugs / Group ACYW135X Meningococcal Conjugate Vaccine
Group ACYW135X Meningococcal Conjugate Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07374510 | Jan → Sep 2026 overdue | meningococcal meningitis | Sinovac Life Sciences Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Group ACYW135X Meningococcal Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07374510 ↗ |
| Modality | Vaccine | “Group ACYW135X Meningococcal Conjugate Vaccine” NCT07374510 ↗ |